I took a look at the numbers again and does look like if they had kept patients on LL for 4 doses or even as long as it takes, we would have done much better. Also, for critical patients it usually took a couple of days for LL to kick in, a couple of days patients didn't have, so at least the first dose should be IV.

Maybe you guys hit on the major thing that will put LL over the top here; perhaps it won't be the FDA that picks it up, maybe Canada, or Brazil or UK.